Skip to main navigation
ANI Pharmaceuticals, Inc.
  • About
    Executive Team Board of Directors Purpose & Values News
  • Rare Disease
    Products Medical Information Portal
  • Generics & Others
  • Investors
  • We're Hiring
    We're Hiring Career Benefits Job Openings Employment Application Exploring Life in Baudette, MN
  • Contact
    Contact Us Locations

News

Investors Menu
  • Overview
  • News
  • Events & Presentations
  • Stock Information
    Stock Quote & Chart Investment Calculator Analyst Coverage
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Documents Executive Team Board of Directors Committee Composition
  • Resources
    Investor FAQs Information Request Form Investor Email Alerts Investor Contacts
11/19/2026
ANI Pharmaceuticals to Present at Upcoming December Investor Conference
11/05/2026
ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results
11/05/2026
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
11/03/2026
ANI Pharmaceuticals to Present at Upcoming November Investor Conferences
10/23/2026
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET
10/19/2026
ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules
10/12/2026
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
09/30/2026
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
09/23/2026
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
09/03/2026
ANI Pharmaceuticals to Present at September Investor Conferences

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 27

Contact Us

INVESTOR CONTACT

Irina Koffler
Vice President, Investor Relations

917-734-7387
envelope icon Irina.koffler@anipharmaceuticals.com

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form
Unsubscribe
ANI Pharmaceuticals, Inc.
Products | Investors | Careers | Contact Us | Privacy Policy | Terms of Use | Accessibility
© Copyright 2026 ANI Pharmaceuticals, Inc.
Linkedin Youtube